Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release

T lymphocytes are used as cellular therapeutics in many disease entities including cancer. We investigated the uptake and retention of nanoparticles (NPs) by these nonphagocytic cells. Uptake, release and toxicity of various polymeric NP preparations were analyzed by flow cytometry, confocal laser s...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine (London, England) Vol. 10; no. 7; pp. 1063 - 1076
Main Authors Zupke, Oliver, Distler, Eva, Jürchott, Anna, Paiphansiri, Umaporn, Dass, Martin, Thomas, Simone, Hartwig, Udo F, Theobald, Matthias, Landfester, Katharina, Mailänder, Volker, Herr, Wolfgang
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:T lymphocytes are used as cellular therapeutics in many disease entities including cancer. We investigated the uptake and retention of nanoparticles (NPs) by these nonphagocytic cells. Uptake, release and toxicity of various polymeric NP preparations were analyzed by flow cytometry, confocal laser scanning microscopy and transmission electron microscopy. T-cell effector functions were measured using IFN-γ-ELISPOT and Chromium-release assays. Amino-functionalized NPs were efficiently ingested by antigen-specific T cells without adversely influencing effector functions. NPs were stored in membrane-surrounded vesicles, with major proportions released extracellularly during 24 h. Amino-functionalized polymeric NPs are efficiently taken up by human T cells and could be used to design nanocarriers for direct access and manipulation of antigen-specific T cells .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1743-5889
1748-6963
DOI:10.2217/nnm.14.160